Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

2.

Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco.

Fucito LM, Bars MP, Forray A, Rojewski AM, Shiffman S, Selby P, West R, Foulds J, Toll BA; Writing Committee for the SRNT Policy and Treatment Networks.

Nicotine Tob Res. 2014 Jul;16(7):909-14. doi: 10.1093/ntr/ntu087. Epub 2014 Jun 11.

PMID:
24919399
3.

Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study.

Kotz D, Brown J, West R.

Psychopharmacology (Berl). 2014 Jan;231(1):37-42. doi: 10.1007/s00213-013-3202-x. Epub 2013 Jul 20.

PMID:
23873417
4.

Assessing the reach of nicotine replacement therapy as a preventive public health measure.

Bondy SJ, Diemert LM, Victor JC, McDonald PW, Cohen JE.

Chronic Dis Inj Can. 2012 Dec;33(1):19-28.

5.

The impact of media campaigns on smoking cessation activity: a structural vector autoregression analysis.

Langley TE, McNeill A, Lewis S, Szatkowski L, Quinn C.

Addiction. 2012 Nov;107(11):2043-50. doi: 10.1111/j.1360-0443.2012.03958.x. Epub 2012 Jul 26.

PMID:
22632403
6.

Prescribing of nicotine replacement therapy to cardiovascular disease patients in England.

Langley TE, Szatkowski L, McNeill A, Coleman T, Lewis S.

Addiction. 2012 Jul;107(7):1341-8. doi: 10.1111/j.1360-0443.2012.03794.x. Epub 2012 Mar 21.

PMID:
22236327
7.

Over-the-counter nicotine replacement therapy for everyone: is it the best solution?

Dome P.

Med Hypotheses. 2011 Dec;77(6):1048-50. doi: 10.1016/j.mehy.2011.08.045. Epub 2011 Sep 15.

PMID:
21924840
8.

State variation in AIDS drug assistance program prescription drug coverage for modifiable cardiovascular risk factors.

Blackstock OJ, Wang KH, Fiellin DA.

J Gen Intern Med. 2011 Dec;26(12):1426-33. doi: 10.1007/s11606-011-1807-5. Epub 2011 Aug 12.

9.

Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials.

Hughes JR, Peters EN, Naud S.

Nicotine Tob Res. 2011 Jul;13(7):512-22. doi: 10.1093/ntr/ntr055. Epub 2011 Apr 6. Review. Erratum in: Nicotine Tob Res. 2012 Dec;14(12):1499.

10.

Evaluation of smoking cessation drug use and outcomes in the Netherlands.

Penning-van Beest FJ, Overbeek JA, Smulders M, van Spiegel PI, Meerding WJ, Herings RM.

J Med Econ. 2011;14(1):124-9. doi: 10.3111/13696998.2010.551165. Epub 2011 Jan 11.

PMID:
21241162
11.

Cautions and warnings on the US OTC label for nicotine replacement: what's a doctor to do?

Zapawa LM, Hughes JR, Benowitz NL, Rigotti NA, Shiffman S.

Addict Behav. 2011 Apr;36(4):327-32. doi: 10.1016/j.addbeh.2010.12.003. Epub 2010 Dec 10. Review.

PMID:
21220188
12.

Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.

Balmford J, Borland R, Hammond D, Cummings KM.

Nicotine Tob Res. 2011 Feb;13(2):94-102. doi: 10.1093/ntr/ntq215. Epub 2010 Dec 8.

13.

Use and acquisition of nicotine replacement therapy products among underaged adolescents after deregulation of the sales.

Rainio SU, Huhtala HS, Rimpelä AH.

Nicotine Tob Res. 2010 Aug;12(8):870-3. doi: 10.1093/ntr/ntq110. Epub 2010 Jul 9.

PMID:
20622024
14.

Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland.

Irvine L, Flynn RW, Libby G, Crombie IK, Evans JM.

Drug Saf. 2010 Jul 1;33(7):593-604. doi: 10.2165/11532330-000000000-00000.

PMID:
20553060
15.

Nicotine replacement therapy use among adolescent smokers seeking cessation treatment.

Botello-Harbaum M, Schroeder JR, Collins CC, Moolchan ET.

Ethn Dis. 2010 Spring;20(2):180-4.

PMID:
20503900
16.

Non-prescription medicines: current issues in Australian community pharmacy.

Tan AC, Emmerton L.

Int J Pharm Pract. 2009 Aug;17(4):207-13.

PMID:
20217945
17.

Disparities in access to over-the-counter nicotine replacement products in New York City pharmacies.

Bernstein SL, Cabral L, Maantay J, Peprah D, Lounsbury D, Maroko A, Murphy M, Shelley D.

Am J Public Health. 2009 Sep;99(9):1699-704. doi: 10.2105/AJPH.2008.149260. Epub 2009 Jul 28.

18.

Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?

Amodei N, Lamb RJ.

Psychol Addict Behav. 2008 Dec;22(4):472-85. doi: 10.1037/0893-164X.22.4.472. Review.

19.

The impact of the 2006 Scottish smoke-free legislation on sales of nicotine replacement therapy.

Lewis SA, Haw SJ, McNeill A.

Nicotine Tob Res. 2008 Dec;10(12):1789-92. doi: 10.1080/14622200802443510.

PMID:
19023830
20.

Supplemental Content

Loading ...
Support Center